1
项与 CD70-CAR-NK cells(The Second Affiliated Hospital Zhejiang University School of Medicine) 相关的临床试验 / Not yet recruiting临床1期IIT Cord Blood-derived CD70-targeting CAR-NK Cell Therapy for Refractory/relapsed T Cell Lymphoma and Acute Myeloid Leukemia
CD70 is a promising target for immunotherapy because it is overexpressed in T-cell lymphoma (TCL) and acute myeloid leukemia (AML) tumor cells but is found in deficient levels in normal tissues and hematopoietic stem cells. This study aims to evaluate the safety and efficacy of CD70-targeted CAR-NK (CD70-CAR-NK) cells in patients with relapsed and refractory TCL and AML.
100 项与 CD70-CAR-NK cells(The Second Affiliated Hospital Zhejiang University School of Medicine) 相关的临床结果
100 项与 CD70-CAR-NK cells(The Second Affiliated Hospital Zhejiang University School of Medicine) 相关的转化医学
100 项与 CD70-CAR-NK cells(The Second Affiliated Hospital Zhejiang University School of Medicine) 相关的专利(医药)
100 项与 CD70-CAR-NK cells(The Second Affiliated Hospital Zhejiang University School of Medicine) 相关的药物交易